Skip to content
10-Q

Quarterly Report

LA JOLLA PHARMACEUTICAL CO

0001564590-21-041197

← back to feed
Filed
Aug 5, 2021 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2021 · Jul 23, 2021 27.49M sh
Current Liabilities Q2 2021 · Jun 30, 2021 $16.1M
Current Liabilities Q2 2021 · Dec 31, 2020 $12.34M
Total Liabilities Q2 2021 · Jun 30, 2021 $167.45M
Total Liabilities Q2 2021 · Dec 31, 2020 $160.33M
Current Assets Q2 2021 · Jun 30, 2021 $65.17M
Current Assets Q2 2021 · Dec 31, 2020 $36.46M
Total Assets Q2 2021 · Jun 30, 2021 $100.01M
Total Assets Q2 2021 · Dec 31, 2020 $72.24M
Cash And Equivalents Q2 2021 · Dec 31, 2020 $21.22M
Cash And Equivalents Q2 2021 · Jun 30, 2020 $68.35M
Shares Diluted Q2 2021 · Jun 30, 2020 27.33M sh
Shares Diluted Q2 2021 · Jun 30, 2020 27.28M sh
Operating Cash Flow Q2 2021 · Jun 30, 2020 −$20.6M
Stockholders Equity Q2 2021 · Jun 30, 2020 −$75.21M
Stockholders Equity Q2 2021 · Mar 31, 2020 −$61.67M
Stockholders Equity Q2 2021 · Dec 31, 2019 −$55.99M
Eps Diluted Q2 2021 · Jun 30, 2020 −$0.57
Eps Diluted Q2 2021 · Jun 30, 2020 −$0.89
Eps Basic Q2 2021 · Jun 30, 2020 −$0.57
Eps Basic Q2 2021 · Jun 30, 2020 −$0.89
Sga Expense Q2 2021 · Jun 30, 2020 $8.68M
Sga Expense Q2 2021 · Jun 30, 2020 $16.83M
Rd Expense Q2 2021 · Jun 30, 2020 $8.78M
Rd Expense Q2 2021 · Jun 30, 2020 $17.96M
Net Income Q2 2021 · Jun 30, 2020 −$15.59M
Net Income Q2 2021 · Jun 30, 2020 −$24.18M
Net Income Q2 2021 · Mar 31, 2020 −$8.59M
Operating Income Q2 2021 · Jun 30, 2020 −$12.46M
Operating Income Q2 2021 · Jun 30, 2020 −$22.92M
Revenue Q2 2021 · Jun 30, 2020 $5.81M
Revenue Q2 2021 · Jun 30, 2020 $13.4M